Company & Sponsor Intelligence

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting0

Completed3

Countries1

Therapeutic footprint

adhdautismepilepsyparkinsons

Indexed studies

NCT02969213Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China
epilepsy · ChinaUNKNOWN

NCT04023201Nocturnal Symptoms and Quality of Life in Patients With Parkinson's Disease in Shanghai
parkinsons · ChinaUNKNOWN

NCT05238298Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial
autism · ChinaNA

NCT05025501A Randomized Controlled Study of Family Based EF Training for Schoolage Children With ADHD
adhd · ChinaNA

NCT04454008RCT of EF Family Training for P ADHD
adhd · ChinaNA

NCT03156153A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
autism · ChinaPHASE2

NCT05472870Efficacy and Mechanism of rTMS in Children With ASD: an Open-label Clinical Trial(Ⅱ)
autism · ChinaNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →